Provided by Tiger Trade Technology Pte. Ltd.

Repligen

181.13
+0.84000.47%
Post-market: 181.00-0.1300-0.07%19:30 EDT
Volume:1.10M
Turnover:198.19M
Market Cap:10.20B
PE:248.12
High:182.43
Open:179.66
Low:175.75
Close:180.29
52wk High:188.73
52wk Low:100.99
Shares:56.29M
Float Shares:53.32M
Volume Ratio:1.05
T/O Rate:2.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.7300
EPS(LYR):0.8600
ROE:1.99%
ROA:1.40%
PB:4.83
PE(LYR):210.62

Loading ...

Repligen Price Target Announced at $160.00/Share by RBC Capital

Dow Jones
·
May 15

U.S. RESEARCH ROUNDUP- Applied Materials, NVIDIA, Thermo Fisher Scientific

Reuters
·
May 15

Repligen Corp : RBC Resumes Coverage With Outperform Rating; Target Price $160

THOMSON REUTERS
·
May 15

Q/C Technologies director Chelsea Sierra Voss acquires 1,753 shares for $5,521.95

Reuters
·
May 15

Repligen resumed with an Outperform at RBC Capital

TIPRANKS
·
May 15

Alphabet Reports Stake In PayPay And CME Group, Dissolves In Dexcom

Reuters
·
May 08

Guggenheim Reaffirms Their Hold Rating on Repligen (RGEN)

TIPRANKS
·
May 08

Repligen Corporation to Present at Bank of America Securities 2026 Global Healthcare Conference

GlobeNewswire
·
May 07

Repligen price target lowered to $165 from $180 at JPMorgan

TIPRANKS
·
May 07

Repligen Is Maintained at Overweight by Barclays

Dow Jones
·
May 06

Repligen (RGEN) Gets a Buy from Stifel Nicolaus

TIPRANKS
·
May 06

Repligen Corp : Jefferies Cuts Target Price to $142 From $152

THOMSON REUTERS
·
May 06

Repligen Earnings Call Highlights Growth, Margin Momentum

TIPRANKS
·
May 06

Repligen price target lowered to $142 from $152 at Jefferies

TIPRANKS
·
May 06

Analysts Offer Insights on Healthcare Companies: Repligen (RGEN) and IQVIA Holdings (IQV)

TIPRANKS
·
May 05

Repligen Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 05

Stock Track | Repligen Soars 5.74% Intraday on Strong Q1 Results, Beats Estimates and Raises Guidance

Stock Track
·
May 05

Repligen Q1 revenue rises 15%, adjusted EPS beats estimates

Reuters
·
May 05

Repligen Q1 GAAP EPS rises 50% to $0.15; revenue increases 15% to $194 million

Reuters
·
May 05

Repligen Q1 Adj. EPS $0.48 Beats $0.39 Estimate, Sales $194.255M Beat $192.279M Estimate

Benzinga Earnings
·
May 05